Parametric Portfolio Associates’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Parametric Portfolio Associates’s Portfolio PRTK Stock Details PRTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$241K	Sell	80,997 -8,341	-9%	-$31.4K	﹤0.01%	3372
2021 Q4	$401K	Sell	89,338 -1,268	-1%	-$6.01K	﹤0.01%	3153
2021 Q3	$440K	Buy	90,606 +3,163	+4%	+$17.4K	﹤0.01%	3158
2021 Q2	$596K	Sell	87,443 -962	-1%	-$7.78K	﹤0.01%	3012
2021 Q1	$624K	Sell	88,405 -3,148	-3%	-$22.7K	﹤0.01%	3390
2020 Q4	$573K	Sell	91,553 -1,823	-2%	-$10.7K	﹤0.01%	3320
2020 Q3	$505K	Sell	93,376 -4,595	-5%	-$22.8K	﹤0.01%	3276
2020 Q2	$511K	Sell	97,971 -31,931	-25%	-$142K	﹤0.01%	3267
2020 Q1	$409K	Sell	129,902 -13,094	-9%	-$48.3K	﹤0.01%	3271
2019 Q4	$576K	Sell	142,996 -100,627	-41%	-$349K	﹤0.01%	3314
2019 Q3	$1.05M	Buy	243,623 +78,175	+47%	+$313K	﹤0.01%	2999
2019 Q2	$660K	Buy	165,448 +94,096	+132%	+$447K	﹤0.01%	3251
2019 Q1	$382K	Buy	71,352 +29,456	+70%	+$190K	﹤0.01%	3460
2018 Q4	$215K	Buy	41,896 +22,601	+117%	+$172K	﹤0.01%	3636
2018 Q3	$187K	Buy	19,295 +4,471	+30%	+$45.1K	﹤0.01%	3777
2018 Q2	$151K	Sell	14,824 -6,007	-29%	-$68K	﹤0.01%	3755
2018 Q1	$271K	Sell	20,831 -42,734	-67%	-$636K	﹤0.01%	3609
2017 Q4	$1.14M	Buy	63,565 +9,988	+19%	+$208K	﹤0.01%	2951
2017 Q3	$1.34M	Sell	53,577 -18,916	-26%	-$440K	﹤0.01%	2854
2017 Q2	$1.75M	Buy	+72,493	New	+$1.6M	﹤0.01%	2638
2014 Q2	–	Sell	-1,225	Closed	-$45K	–	3808
2014 Q1	$45K	Sell	1,225 -32	-3%	-$1.26K	﹤0.01%	3787
2013 Q4	$51K	Buy	1,257 +13	+1%	+$552	﹤0.01%	3776
2013 Q3	$47K	Sell	1,244 -61	-5%	-$2.18K	﹤0.01%	3778
2013 Q2	$47K	Buy	+1,305	New	+$55.9K	﹤0.01%	3665

Other funds holding PRTK

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Bruce & Co Chicago, Illinois $350M AUM 33.5% 1-Year Est. Return

GAI

General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

FIG

Fortress Investment Group New York $394M AUM 22.99% 1-Year Est. Return

Parametric Portfolio Associates's PRTK Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its Paratek Pharmaceuticals, Inc. (PRTK) stake by 9.3% in Q1 2022, selling an estimated $31.4K and leaving 80,997 shares worth $241K. The position accounts for ﹤0.01% of the portfolio, ranked #3372.

Parametric Portfolio Associates first reported a position in PRTK in Q2 2013 and has held it in 24 quarters since. The position peaked at $1.75M in Q2 2017. 100 funds tracked by Wall St. Rank hold PRTK as of Q1 2022.

Parametric Portfolio Associates held 80,997 shares of Paratek Pharmaceuticals, Inc. worth $241K as of Q1 2022.
Parametric Portfolio Associates sold 8,341 Paratek Pharmaceuticals, Inc. shares in Q1 2022, an estimated $31.4K.
Paratek Pharmaceuticals, Inc. made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3372 holding.
Parametric Portfolio Associates first reported a position in Paratek Pharmaceuticals, Inc. in Q2 2013 and has held it in 24 quarters since.
Parametric Portfolio Associates's Paratek Pharmaceuticals, Inc. position peaked at $1.75M in Q2 2017.
100 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.